Tirzepatide
Mounjaro, also known as tirzepatide, is a dual GIP and GLP-1 receptor agonist primarily used for weight management and glycemic control. It enhances insulin secretion and reduces appetite, making it a promising compound for obesity and type 2 diabetes management, which are critical factors in longevity and metabolic health.
Member access required
Clinical protocols and outcomes data are available to AXIFI Members and Providers.